Selected clinically stable patients with heart failure (HF) who require prolonged intravenous inotropic therapy may benefit from its continuity out of the intensive care unit (ICU). We aimed to report on the initial experience and safety of a structured protocol for inotropic therapy in non-intensive care units in 28 consecutive patients hospitalized with HF that were discharged from ICU. The utilization of low to moderate inotropic doses oriented by a safety-focused process of care may reconfigure their role as a transition therapy while awaiting definitive advanced therapies and enable early ICU discharge.
Continuous Intravenous Inotropes in Ward Units: Expanding Therapy Outside Intensive Care using a Safety-Oriented Protocol
HastenteufelLCT, ClausellN, NeyeloffJL, DominguesFB, CaballeroLG, SilvaERR, GoldraichLA. Continuous Intravenous Inotropes in Ward Units: Expanding Therapy Outside Intensive Care using a Safety-Oriented Protocol. Arq. Bras. Cardiol. 2019;112(5):573-6.
Hastenteufel,Laura Caroline Tavares; Clausell,Nadine; Neyeloff,Jeruza Lavanholi; Domingues,Fernanda Bandeira; Caballero,Larissa Gussatschenko; Silva,Eneida Rejane Rabelo da; Goldraich,Lívia Adams. Continuous Intravenous Inotropes in Ward Units: Expanding Therapy Outside Intensive Care using a Safety-Oriented Protocol. Arq. Bras. Cardiol., v. 112, n. 5, p. 573-576, May. 2019.
Hastenteufel,L.C.T., Clausell,N., Neyeloff,J.L., Domingues,F.B., Caballero,L.G., Silva,E.R.R. , & Goldraich,L.A. (2019). Continuous Intravenous Inotropes in Ward Units: Expanding Therapy Outside Intensive Care using a Safety-Oriented Protocol. Arq. Bras. Cardiol.,112(5), 573-576.
Hastenteufel,Laura Caroline Tavares and Clausell,Nadine and Neyeloff,Jeruza Lavanholi and Domingues,Fernanda Bandeira and Caballero,Larissa Gussatschenko and Silva,Eneida Rejane Rabelo da and Goldraich,Lívia Adams. Continuous Intravenous Inotropes in Ward Units: Expanding Therapy Outside Intensive Care using a Safety-Oriented Protocol. Arq. Bras. Cardiol. [online]. 2019, vol. 112, n. 5, [cited 2025-09-07], pp.573-576. Available from: <https://abccardiol.org/en/article/continuous-intravenous-inotropes-in-ward-units-expanding-therapy-outside-intensive-care-using-a-safety-oriented-protocol/>. ISSN 0066-782X.
Figure 1
Dyslipidemia as a central element in atherosclerotic cardiovascular disease. ASCVD: atherosclerotic cardiovascular disease; LDL-C: low-density lipoprotein cholesterol. Limitations of statin-based therapy (non-exhaustive) include suboptimal LDL-C goal attainment, statin-associated adverse effects that may affect adherence, and potential drug interactions. Residual risk reflects the involvement of multiple underlying pathways.